CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
17 Febrero 2016 - 5:00AM
CombiMatrix Corporation (NASDAQ:CBMX), a molecular diagnostics
company specializing in DNA-based testing services for prenatal,
miscarriage analysis and postnatal developmental disorders and
pre-implantation genetic screening (PGS) services, announces that
it has received a letter from the NASDAQ Listing Qualifications
Staff notifying the Company that it has regained full compliance
with NASDAQ's minimum bid price continued listing requirement.
The letter, received February 16, 2016, noted
that the closing bid price of CombiMatrix’s common stock has been
at $1.00 per share or higher for the last 10 consecutive business
days, from February 1, 2016 to February 12, 2016. Accordingly, the
Company has regained compliance with Listing Rule 5550(a)(2) and
this matter is now closed. There can be no assurance, however, that
the Company will be able to maintain compliance with the minimum
bid price requirement in the future.
About CombiMatrix
Corporation
CombiMatrix Corporation provides valuable
molecular diagnostic solutions and comprehensive clinical support
to foster the highest quality in patient care. CombiMatrix
specializes in pre-implantation genetic screening, miscarriage
analysis, prenatal and pediatric diagnostics, offering DNA-based
testing for the detection of genetic abnormalities beyond what can
be identified through traditional methodologies. CombiMatrix
performs genetic testing utilizing a variety of advanced
cytogenomic techniques, including chromosomal microarray,
standardized and customized fluorescence in situ hybridization
(FISH) and high-resolution karyotyping. CombiMatrix is dedicated to
providing high-level clinical support for healthcare professionals
in order to help them incorporate the results of complex genetic
testing into patient-centered medical decision making. Additional
information about CombiMatrix is available at www.combimatrix.com
or by calling (800) 710-0624.
Company Contact:
Mark McDonough
President & CEO, CombiMatrix Corporation
(949) 753-0624
Investor Relations Contact:
LHA
Jody Cain
(310) 691-7100
jcain@lhai.com
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Gráfica de Acción Histórica
De Jun 2024 a Jul 2024
Combimatrix Corp. (MM) (NASDAQ:CBMX)
Gráfica de Acción Histórica
De Jul 2023 a Jul 2024
Real-Time news about Combimatrix Corp. (MM) (NASDAQ): 0 recent articles
Más de Artículos de Noticias